ClinicalTrials.Veeva

Menu

Invasive Aspergillosis After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)

O

Ospedale Santa Croce-Carle Cuneo

Status

Unknown

Conditions

Invasive Aspergillosis
Hematological Diseases

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Evaluation of incidence of invasive aspergillosis in patients who have undergone an allogeneic stem cell transplantation, with particular regard to the role of galactomannan assay and of early TC scan in asymptomatic patients.

Enrollment

220 patients

Sex

All

Ages

16+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age > 16 years
  • Allogeneic HSCT for a haematological disease
  • Written informed consent to the study

Exclusion criteria

  • Pediatric patients

Trial design

220 participants in 1 patient group

Allogeneic pts
Description:
Adult allogeneic HSCT recipients

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems